| Literature DB >> 30787765 |
Lubna Ghenem1, Nasreldin Elhadi1, Faisal Alzahrani1, Mitsuaki Nishibuchi2.
Abstract
Vibrio parahaemolyticus is a Gram-negative, halophilic bacterium isolated from marine environments globally. After the consumption of contaminated seafood, V. parahaemolyticus causes acute gastroenteritis. To initiate infection, a wide range of virulence factors are required. A complex group of genes is known to participate in the pathogenicity of V. parahaemolyticus; however, to understand the full mechanism of infection, extensive research is yet required. V. parahaemolyticus has become the leading cause of seafood-related gastroenteritis in Japan, the United States and several other parts of the world. In addition, outbreaks caused by the pandemic clone of this organism are escalating and spreading universally. To minimize the risk of V. parahaemolyticus infection and warrant the safety of seafood, collaboration between governments and scientists is required. We herein provide an updated review of the pathogenicity determinants and distribution of V. parahaemolyticus to deliver a better understanding of the significance of V. parahaemolyticus and its host-pathogen interactions.Entities:
Keywords: Pandemic clone; Vibrio Parahaemolyticus; pathogenesis; virulence determinants
Year: 2017 PMID: 30787765 PMCID: PMC6298368 DOI: 10.4103/sjmms.sjmms_30_17
Source DB: PubMed Journal: Saudi J Med Med Sci ISSN: 2321-4856
List of Vibrio parahaemolyticus type III secretion systems effectors
| T3SS | T3SS effectors | Activity | References |
|---|---|---|---|
| T3SS1 | VopQ | Rapid induction of autophagy leading to debilitated phagocytes engulfment of | [ |
| VopS | Actin assembly inhibition | [ | |
| VPA0450 | Compromises membranes integrity, facilitates cell lysis and participates in cytotoxicity | [ | |
| VopR | May play a role in infection by promoting refolding of T3SS effector proteins after their delivery into host cell | [ | |
| T3SS2 | VopA/P (VPA1346) | Suppresses the host innate immune response | [ |
| VopL | Actin nucleation, induction of stress fibers and contribute to bacterial uptake into the host cells | [ | |
| VopC | Changes in actin cytoskeleton and facilitates bacterial invasion | [ | |
| VopT | Cytotoxicity | [ | |
| VopV | Enterotoxicity | [ | |
| VopZ | Mediates pathological phenotypes during | [ | |
| VPA1380 | Unknown | [ |
T3SS – Type III secretion systems; Vop – Vibrio outer protein; V. parahaemolyticus – Vibrio parahaemolyticus
Figure 1World map presenting the global dissemination of V. parahaemolyticus (illustrative representation of Table 2)
Overview of the global clinical and environmental distribution of Vibrio parahaemolyticus
| Continent | Country | Source(s) | Pandemic serotypes | Reference(s) |
|---|---|---|---|---|
| Asia | Japan | Clinical and environmental | Yes | [ |
| Korea | Clinical and environmental | Yes | [ | |
| China | Clinical and environmental | Yes | [ | |
| Vietnam | Clinical and environmental | Yes | [ | |
| Laos | Clinical and environmental | Yes | [ | |
| Indonesia | Clinical and environmental | Yes | [ | |
| Malaysia | Clinical and environmental | No | [ | |
| Singapore | Clinical and environmental | Yes | [ | |
| Thailand | Clinical and environmental | Yes | [ | |
| India | Clinical and environmental | Yes | [ | |
| Bangladesh | Clinical and environmental | Yes | [ | |
| Jordan | Environmental | No | [ | |
| Europe | Russia | Clinical and environmental | Yes | [ |
| Sweden | Environmental | No | [ | |
| Norway | Environmental | Potentially yes | [ | |
| United Kingdom | Clinical and environmental | Yes | [ | |
| Spain | Clinical and environmental | Yes | [ | |
| France | Clinical and environmental | Yes | [ | |
| Italy | Clinical and environmental | Yes | [ | |
| Switzerland | Environmental | No | [ | |
| Germany | Environmental | No | [ | |
| Turkey (Black Sea) | Environmental | No | [ | |
| Africa | Egypt | Environmental | No | [ |
| Tunisia | Environmental | No | [ | |
| Nigeria | Environmental | No | [ | |
| Kenya | Environmental | No | [ | |
| Mozambique | Clinical and environmental | Yes | [ | |
| Côte d’Ivoire | Environmental | No | [ | |
| Senegal | Environmental | No | [ | |
| South Africa | Environmental | No | [ | |
| Guinea-Bissau | Environmental | No | [ | |
| America | Canada | Clinical and environmental | No | [ |
| United States | Clinical and environmental | Yes | [ | |
| Mexico | Clinical and environmental | Yes | [ | |
| Ecuador | Clinical and environmental | Yes | [ | |
| Brazil | Clinical and environmental | Yes | [ | |
| Peru | Clinical and environmental | Yes | [ | |
| Chile | Clinical and environmental | Yes | [ |